Press release
Bioimpedance Analyzers Market 2021: Modality, Type, Application, End User, CAGR and Key Players Omron Corporation, Tanita Corporation, InBody, RJL Systems, seca GmbH & Co. KG
The Bioimpedance Analyzers Market report provides a detailed analysis, of the market for the period of start year-end year. The report provides information about the CAGR, sales, and revenue studying the historical data and making an estimation of the revenue growth till the forecast period. The key objective of this Bioimpedance Analyzers Market report is to deliver an all-inclusive summary including the market share, market size, opportunities, market influencers, challenges, driving factors, and growth rate, by the deep-dive study of the leading market players of the Medical Devices industry from different geographical locations, their product/service types and application industries.Get a FREE Sample Copy of this Report with Graphs and Charts at: https://www.reportsnreports.com/contacts/requestsample.aspx?name=4836203
The global bioimpedance analyzers market size is projected to reach USD 767 million by 2026 from USD 429 million in 2021, at a CAGR of 10.2% from 2021 to 2026.
List of Companies Profiled in the Report
Omron Corporation (Japan)
Tanita Corporation (Japan)
InBody (South Korea)
RJL Systems (US),
seca GmbH & Co. KG (Germany)
EVOLT 360 (Australia)
SELVAS Healthcare (South Korea)
Charder Electronic Co. Ltd. (China)
Fook Tin Group Holding Ltd. (China)
Bodystat Ltd. (UK), Maltron International (UK)
Biotekna (Italy), Withings (France)
Biodynamics Corporation (US)
Akern (Italy)
Xiaomi (China)
Sino-Hero (Shenzhen)
Bio-Medical Electronics Co., Ltd. (China)
Lumsail Industrial Inc. (China)
Guangzhou Beautylife Electronic Technology Co., Ltd. (China)
Bioparhom (France)
Breakdown of supply-side primary interviews, by company type, designation, and region:
By Company Type: Tier 1 (32%), Tier 2(44%), and Tier 3 (24%)
By Designation: C-level (30%), Director-level (34%), and Others (36%)
By Region: North America (40%), Europe (28%), AsiaPacific(20%), and Rest of the World(12%)
Growth in this market is driven by the growing prevalence of lifestyle diseases such as obesity, increasing awareness on healthy lifestyles, and the growing number of fitness clubs, weight loss clinics, and sports rehabilitation centers.
“Multi-frequency bioimpedance analyzers segment to witness the highest growth during the forecast period.”
Based on the product, the bioimpedance analyzers market is segmented into multi-frequency bioimpedance analyzers, single-frequency bioimpedance analyzers, and dual-frequency bioimpedance analyzers. The consumables segment is projected to grow at the highest CAGR during the forecast period. The increasing prevalence of diseases, the growing focus on drug discovery, and the rising R&D expenditure by pharmaceutical companies are the major factor supporting the growth of this segment.
“Wireless bioimpedance modality segment to register the highest growth in the bioimpedance analyzers market during the forecast period.”
Based on the modality, the bioimpedance analyzers market is segmented into wired bioimpedance analyzers and wireless bioimpedance analyzers. The wireless bioimpedance analyzers segment is projected to witness the highest growth in the bioimpedance analyzers market during the forecast period. The advancements in and the growing demand for wireless technologies are the major factors supporting the growth of this segment.
“Asia Pacific is estimated to register the highest CAGR during the forecast period.”
In this report, the bioimpedance analyzers market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). The market in Asia Pacific is projected to register the highest growth rate during the forecast period. The growth in this market is primarily driven by the rising obesity rates in China, growing awareness about health and fitness, and the strong foothold of local players in Japan.
Reasons to Buy the Report:
The report provides insights on the following pointers:
Market Penetration: Comprehensive information on bioimpedance analyzers products offered by the top 20players in the bioimpedance analyzers market. The report analyzes the bioimpedance analyzers market by product, modality, application, end-user, and region.
Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various securement devices across key geographic regions.
Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the bioimpedance analyzers market
Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the bioimpedance analyzers market
Get 20% Discount on this Research Report at: https://www.reportsnreports.com/contacts/discount.aspx?name=4836203
Table Of Contents
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.2.1 Inclusions And Exclusions
1.3 Market Scope
1.3.1 Market Segmentation
1.3.2 Years Considered For The Study
1.4 Currency
1.5 Limitations
1.6 Market Stakeholders
2 Research Methodology
2.1 Research Data
Figure 1 Research Design
2.1.1 Secondary Data
2.1.1.1 Secondary Sources
2.1.2 Primary Data
Figure 2 Primary Sources
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
Figure 3 Breakdown Of Primary Interviews: By Company Type, Designation, And Region
2.2 Market Size Estimation
Figure 4 Cagr Projections: Supply-Side Analysis
Figure 5 Top-Down Approach
2.3 Market Breakdown And Data Triangulation
Figure 6 Data Triangulation Methodology
2.4 Market Share
2.5 Assumptions For The Study
2.6 Covid-19 Specific Assumptions
2.7 Risk Assessment/Factor Analysis
Table 1 Risk Assessment/Factor Analysis
2.8 Covid-19 Health Assessment
2.9 Covid-19 Economic Assessment
2.10 Assessment Of The Impact Of Covid-19 On The Economic Scenario
3 Executive Summary
Figure 9 Bioimpedance Analyzers Market, By Product, 2021 Vs. 2026 (Usd Million)
Figure 10 Bioimpedance Analyzers Market, By Modality, 2021 Vs. 2026 (Usd Million)
Figure 11 Bioimpedance Analyzers Market, By Application, 2021 Vs. 2026 (Usd Million)
Figure 12 Bioimpedance Analyzers Market, By End User, 2021 Vs. 2026 (Usd Million)
Figure 13 Bioimpedance Analyzers Market, By Region, 2021 Vs. 2026 (Usd Million)
4 Premium Insights
4.1 Bioimpedance Analyzers Market Overview
Figure 14 Increasing Incidence Of Lifestyle Diseases To Drive Market Growth During The Forecast Period
4.2 Bioimpedance Analyzers Market, By Application
Figure 15 Segmental Body Measurement Segment Accounted For The Largest Market Share In 2020
4.3 North America: Bioimpedance Analyzers Market, By Product And Country, 2020
Figure 16 Multi-Frequency Bioimpedance Analyzers Dominated The North American Market In 2020
4.4 Geographical Snapshot Of The Bioimpedance Analyzers Market
Figure 17 China To Register The Highest Growth During The Forecast Period
5 Market Overview
6 Bioimpedance Analyzers Market, By Product
7 Bioimpedance Analyzers Market, By Modality
8 Bioimpedance Analyzers Market, By Application
9 Bioimpedance Analyzers Market, By End User
10 Bioimpedance Analyzers Market, By Region
Purchase this report at: https://www.reportsnreports.com/purchase.aspx?name=4836203
CONTACT INFO:
Magarpatta City, Hadapsar, Pune, India - 411013
+ 1 888 391 5441
sales@businessworldeco.com
businessworldeco.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bioimpedance Analyzers Market 2021: Modality, Type, Application, End User, CAGR and Key Players Omron Corporation, Tanita Corporation, InBody, RJL Systems, seca GmbH & Co. KG here
News-ID: 2385546 • Views: …
More Releases from ReportsnReports

DeviceCon Series 2024 - UK Edition | MarketsandMarkets
Future Forward: Redefining Healthcare with Cutting-Edge Devices
Welcome to DeviceCon Series 2024 - Where Innovation Meets Impact!
Join us on March 21-22 at Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH for a groundbreaking convergence of knowledge, ideas, and technology. MarketsandMarkets proudly presents the DeviceCon Series, an extraordinary blend of four conferences that promise to redefine the landscape of innovation in medical and diagnostic devices.
Register Now @ https://events.marketsandmarkets.com/devicecon-series-uk-edition-2024/register
MarketsandMarkets presents…

5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Confer …
London, March 7, 2024 - MarketsandMarkets is thrilled to announce the eagerly awaited 5th Annual Infectious Disease and Molecular Diagnostics Conference, scheduled to take place on March 21st - 22nd, 2024, at the prestigious Millennium Gloucester Hotel, located at 4-18 Harrington Gardens, London SW7 4LH.
This conference promises to be a groundbreaking event, showcasing the latest trends and insights in diagnosis, as well as unveiling cutting-edge technologies that are revolutionizing the…

Infection Control, Sterilization & Decontamination Conference |21st - 22nd March …
MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21-22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays.
Enquire Now @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/
This conference aims to bring together all the stakeholders to discuss the obstacles in achieving…

Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, S …
The global Breast Augmentation Market in terms of revenue was estimated to be worth $900 million in 2020 and is poised to reach $1,692 million by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying…
More Releases for Bioimpedance
Bioimpedance Device Market: A Guide to Understanding the Process
The global Bioimpedance Device Market is estimated to be valued at USD 1.2 billion in 2024 and is anticipated to reach USD 2.8 billion by 2033, growing at a CAGR of 10.2% during the forecast period from 2025 to 2033.
Bioimpedance Device Market Overview
The Bioimpedance Device Market is witnessing steady growth driven by increasing applications in healthcare diagnostics, fitness monitoring, and body composition analysis. These devices measure electrical impedance to…
Primary Catalyst Driving Bioimpedance Analyzers Market Evolution in 2025: Rising …
"What Is the Future Outlook for the Bioimpedance Analyzers Market's Size and Growth Rate?
The market capacity of bioimpedance analyzers has expanded significantly over the past few years, with the projection to rise from $0.59 billion in 2024 to $0.67 billion in 2025, reflecting a compound annual growth rate (CAGR) of 14.5%. Factors contributing to the growth during the historical period include the escalating obesity crisis, evolving lifestyle trends, a surge…
Bioimpedance Analyzers Market worth $927 million by 2028
Bioimpedance Analyzers Market in terms of revenue was estimated to be worth $564 million in 2023 and is poised to reach $927 million by 2028, growing at a CAGR of 10.4% from 2023 to 2028 according to a new report by MarketsandMarkets™. The growth of this market is majorly driven by rising initiatives by government in promoting healthy lifestyle to curb obesity, growing number of gyms and wellness centers, strong…
Bioimpedance Analyzers Market to reach USD 927 million by 2028
"The rise in obesity rate is expected to drive the demand of the market."
The global bioimpedance analyzers market is projected to reach USD 927 million by 2028 from USD 564 million in 2023, at a CAGR of 10.4% during the forecast period. The growth of this market is majorly driven by the promotion of healthy lifestyles by the government, growing fitness and wellness centers, and an increase in the number…
Bioimpedance Analyzers Market: Global Industry Analysis And Forecast 2023 - 2029
Market Overview:
The Global Bioimpedance Analyzers market was valued at USD 465.58 million in 2021 and is expected to reach USD 836.45 million by the year 2028, at a CAGR of 8.73%.
The screening instrument that can be used to measure and accurately analyze body composition and body fat is known as a bioimpedance analyzer (BIA). It is a non-invasive instrument that doctors use to calculate body fat percentage. Additionally, it enables…
Single-frequency Bioimpedance Devicess Market: Competitive Dynamics & Global Out …
New report published by Market Research Report Store (MRRS) which offers insights on the global Single-frequency Bioimpedance Devicess market.
Click to view the full report TOC, figure and tables:
https://www.marketresearchreportstore.com/reports/242079/global-single-frequency-bioimpedance-devicess-market
Global Single-frequency Bioimpedance Devicess Market: Forecast by Type / Application / Region
According to this study, over the next five years the Single-frequency Bioimpedance Devicess market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million…